Lupin denies quality is a company-wide issue despite run ins with FDA
Lupin refutes suggestion that history of manufacturing quality failings highlighted by the US FDA reflect a company-wide issue.
Lupin refutes suggestion that history of manufacturing quality failings highlighted by the US FDA reflect a company-wide issue.
Aiming to improve flexibility in bioprocessing, Eppendorf launches SciVario twin, a bioreactor control system enabling remote monitoring of microbial and cell culture processes.
Tetra Bio-Pharma signs agreement for the commercial manufacture of two CBD-based drug candidates.
ACG Inspection rides the technology wave with the launch of a blockchain-based software platform, aiming to meet industry demands on traceability.
IQVIA warns coronavirus outbreak is stopping study participants from visiting clinical trial sites.